The real-world effectiveness of fluvoxamine therapy in mild to moderate COVID-19 patients; A historical cohort study (Fluvoxa Trial)

Background: Fluvoxamine (FVX) has been proposed as a potential treatment for severe COVID-19 by the σ-1 receptor agonist, which can reduce cytokine production. However, the efficacy of FVX remains controversial. Methods: A historical retrospective cohort study was conducted in mild to moderate COVID...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Taweegrit Siripongboonsitti (Auteur), Kriangkrai Tawinprai (Auteur), Paruspak Payoong (Auteur), Nithi Mahanonda (Auteur)
Formaat: Boek
Gepubliceerd in: Elsevier, 2023-12-01T00:00:00Z.
Onderwerpen:
Online toegang:Connect to this object online.
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Internet

Connect to this object online.

3rd Floor Main Library

Exemplaargegevens van 3rd Floor Main Library
Plaatsingsnummer: A1234.567
Kopie 1 Beschikbaar